Literature DB >> 2550538

Effects of neuropeptide Y on the renal, mesenteric and hindlimb vascular beds of the conscious rabbit.

R Minson1, R McRitchie, J Chalmers.   

Abstract

The effects of neuropeptide Y (NPY, 10 micrograms/kg bolus i.v.) on renal, mesenteric and hindlimb blood flow were determined in intact conscious rabbits with chronically implanted Doppler ultrasonic flow transducers. The role of sympathetic neuro-effectors was assessed using inhibition of peripheral alpha-adrenoceptors with phentolamine in each group, and in the renal flow group following chemical sympathectomy with 6-hydroxydopamine. In controls, NPY caused markedly non-uniform peak responses. Renal blood flow fell from 2.16 +/- 0.12 kHz to a minimum of 0.26 +/- 0.07 kHz following NPY administration (P less than 0.05). Mesenteric blood flow was reduced from 2.04 +/- 1.17 to 1.54 +/- 0.11 kHz (P less than 0.05). blood flow increased transiently from 2.33 +/- 0.15 to a peak of 3.33 +/- 0.19 kHz (P less than 0.05). Renal vascular resistance rose by 1189 +/- 309% and mesenteric resistance by 54 +/- 9% (P less than 0.05), while hindlimb resistance fell by 24 +/- 3% (P less than 0.05). Pretreatment with phentolamine accentuated the peak pressor response and the reduction in heart rate induced by NPY administration but had little effect on the local haemodynamic changes in each vascular bed. There was no change in the renal vascular response to NPY following sympathectomy. Indeed, the peak NPY-induced reduction in renal blood flow seen in control animals (87 +/- 4%) was unaffected by either alpha-adrenoceptor inhibition (90 +/- 5%) or by sympathectomy (86 +/- 5%). In conscious rabbits with intact cardiovascular reflexes, pharmacological doses of NPY cause profound renal vasoconstriction with smaller changes in mesenteric and hindlimb flow.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2550538     DOI: 10.1016/0165-1838(89)90095-7

Source DB:  PubMed          Journal:  J Auton Nerv Syst        ISSN: 0165-1838


  5 in total

1.  Effects of neuropeptide-Y on renal function and its interaction with sympathetic stimulation in conscious dogs.

Authors:  P B Persson; H Ehmke; B Nafz; R Lang; E Hackenthal; R Nobiling; M S Dietrich; H R Kirchheim
Journal:  J Physiol       Date:  1991-12       Impact factor: 5.182

2.  Neuropeptide Y-enhanced diuresis and natriuresis in anaesthetized rats is independent of renal blood flow reduction.

Authors:  A Bischoff; W Erdbrügger; J Smits; M C Michel
Journal:  J Physiol       Date:  1996-09-01       Impact factor: 5.182

3.  Plasma neuropeptide Y (NPY) and alpha-melanocyte stimulating hormone (a-MSH) levels in patients with or without hypertension and/or obesity: a pilot study.

Authors:  Maria Baltazi; Niki Katsiki; Christos Savopoulos; Fotios Iliadis; George Koliakos; Apostolos I Hatzitolios
Journal:  Am J Cardiovasc Dis       Date:  2011-05-20

4.  Renovascular effects of neuropeptide-Y in the split hydronephrotic rat kidney: non-uniform pattern of vascular reactivity.

Authors:  M S Dietrich; M Fretschner; R Nobiling; P B Persson; M Steinhausen
Journal:  J Physiol       Date:  1991-12       Impact factor: 5.182

Review 5.  The gut-renal axis: do incretin-based agents confer renoprotection in diabetes?

Authors:  Marcel H A Muskiet; Mark M Smits; Linde M Morsink; Michaela Diamant
Journal:  Nat Rev Nephrol       Date:  2013-12-24       Impact factor: 28.314

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.